Genentech lays off 103 alongside gRED rethink, pens $490M breast cancer collab

Genentech to lay off 103 workers at South San Francisco headquarters

Genentech is laying off 103 workers at its South San Francisco headquarters, with the cuts taking effect July 29. This marks another round o

Remix does reverse merger with Passage Bio for mRNA degrader

GSK acquires cancer drug developer Nuvalent in $10.6 billion deal

GSK has announced a $10.6 billion acquisition of Nuvalent, a biotech company developing small-molecule kinase inhibitors for treatment-resis

Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis

Myricx Bio, a cancer therapy spinout from the Francis Crick Institute and Imperial College London, has agreed to be acquired by Novartis in

Anne Wojcicki's Nonprofit Acquires 23andMe for $305 Million

Anne Wojcicki's nonprofit, TTAM Research Institute, has successfully outbid Regeneron Pharmaceuticals to acquire 23andMe for $305 million, i

Meta plans to lay off 10% of staff, approximately 8,000 employees, in May

Meta is planning to lay off approximately 10% of its workforce (around 8,000 employees) in May 2025, according to a memo from Chief People O